e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Growth factors and fibrogenesis: are they good, bad or both?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment
A. Leuenberger, L. Knudsen, A. Gazdhar, T. Geiser, M. Ochs (Bern, Switzerland; Hannover, Germany)
Source:
Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Session:
Growth factors and fibrogenesis: are they good, bad or both?
Session type:
Oral Presentation
Number:
3235
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Leuenberger, L. Knudsen, A. Gazdhar, T. Geiser, M. Ochs (Bern, Switzerland; Hannover, Germany). Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment. Eur Respir J 2011; 38: Suppl. 55, 3235
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Risk factors associated with the development of interstitial lung abnormalities
Related content which might interest you:
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Human hepatocyte growth factor levels in patients undergoing thoracic operations
Source: Eur Respir J 2006; 27: 73-76
Year: 2006
Nerve growth factor levels and localisation in human asthmatic bronchi
Source: Eur Respir J 2002; 20: 1110-1116
Year: 2002
Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006
Expression and role of the nerve growth factor NGF in pulmonary hypertension
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001
Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Synergistic effect of cysteinyl-leukotrienes and epidermal growth factor on human lung fibroblast mitogenesis
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005
Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts
Source: Eur Respir J 2008; 31: 21-28
Year: 2008
Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 183-193
Year: 2011
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts
Source: Eur Respir J 2003; 22: Suppl. 45, 7s
Year: 2003
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001
Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Hepatocyte growth factor prevents airway remodelling in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept